Literature DB >> 23056032

Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings.

A K Musubire1, B D Meya, H Mayanja-Kizza, R Lukande, L D Wiesner, P Bohjanen, R D R Boulware.   

Abstract

In many resource-limited settings, cryptococcal meningitis (CM) contributes up to 20% of all deaths with further complications due to Immune Reconstitution Inflammatory Syndrome (IRIS). We present a case report on a patient who developed CM-IRIS and then subsequent CM-relapse with a fluconazole-resistant organism and then later CM-IRIS once again, manifesting as cystic cryptococcomas, hydrocephalus, and sterile CSF. In this case we, demonstrate that CM-IRIS and persistent low level cryptococcal infection are not mutually exclusive phenomena. The management of IRIS with corticosteroids may increase the risk of culture positive CM-relapse which may further increase the risk of recurrent IRIS and resulting complications including death. We also highlight the role of imaging and fluconazole resistance testing in patients with recurrent meningitis and the importance of CSF cultures in guiding treatment decisions.

Entities:  

Keywords:  AIDS; Cryptococcal Meningitis; HIV; Immune reconstitution inflammatory Syndrome; antiretroviral therapy

Mesh:

Substances:

Year:  2012        PMID: 23056032      PMCID: PMC3462548          DOI: 10.4314/ahs.v12i2.23

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  14 in total

1.  Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy.

Authors:  Guillaume Breton; Danielle Seilhean; Patrick Chérin; Serge Herson; Olivier Benveniste
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

2.  Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection.

Authors:  Anna Maria Cattelan; Marco Trevenzoli; Lolita Sasset; Massimiliano Lanzafame; Umberto Marchioro; Francesco Meneghetti
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

Review 3.  HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Thomas S Harrison
Journal:  AIDS       Date:  2007-10-18       Impact factor: 4.177

Review 4.  MRI findings of intramedullary spinal cryptococcoma.

Authors:  Neslihan Zehra Gültaşli; Karabekir Ercan; Sibel Orhun; Serdal Albayrak
Journal:  Diagn Interv Radiol       Date:  2007-06       Impact factor: 2.630

5.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

Review 6.  [Subacute meningoradiculomyeloencephalitis due to cryptococcosis infection].

Authors:  A Drouet; Y Amah; M Pavic; P Gérome; X Meyer; P Debourdeau
Journal:  Rev Med Interne       Date:  2005-01-19       Impact factor: 0.728

Review 7.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

8.  Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.

Authors:  Joseph N Jarvis; Graeme Meintjes; Zomzi Williams; Kevin Rebe; Thomas S Harrison
Journal:  S Afr Med J       Date:  2010-06

9.  Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.

Authors:  David R Boulware; David B Meya; Tracy L Bergemann; Darin L Wiesner; Joshua Rhein; Abdu Musubire; Sarah J Lee; Andrew Kambugu; Edward N Janoff; Paul R Bohjanen
Journal:  PLoS Med       Date:  2010-12-21       Impact factor: 11.069

10.  Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.

Authors:  Lewis J Haddow; Robert Colebunders; Graeme Meintjes; Stephen D Lawn; Julian H Elliott; Yukari C Manabe; Paul R Bohjanen; Somnuek Sungkanuparph; Philippa J Easterbrook; Martyn A French; David R Boulware
Journal:  Lancet Infect Dis       Date:  2010-11       Impact factor: 25.071

View more
  16 in total

1.  Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid.

Authors:  Richard Kwizera; Andrew Akampurira; Tadeo K Kandole; Maria S Nabaggala; Darlisha A Williams; Andrew Kambugu; David B Meya; Joshua Rhein; David R Boulware
Journal:  Med Mycol       Date:  2018-07-01       Impact factor: 4.076

2.  Diagnosis and Management of Cryptococcal Relapse.

Authors:  Abdu K Musubire; David R Boulware; David B Meya; Joshua Rhein
Journal:  J AIDS Clin Res       Date:  2013-04-29

3.  Central nervous system immune reconstitution inflammatory syndrome.

Authors:  Nathan Bahr; David R Boulware; Suzaan Marais; James Scriven; Robert J Wilkinson; Graeme Meintjes
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

4.  Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.

Authors:  Thomas Kalinoski; Jason Malenfant; Catherine Yim; Arthur Jeng
Journal:  Am J Trop Med Hyg       Date:  2020-04-23       Impact factor: 2.345

Review 5.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

6.  Development of cryptococcal immune reconstitution inflammatory syndrome 41 months after the initiation of antiretroviral therapy in an AIDS patient.

Authors:  Hideki Hashimoto; Shuji Hatakeyama; Hiroshi Yotsuyanagi
Journal:  AIDS Res Ther       Date:  2015-09-30       Impact factor: 2.250

7.  Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan.

Authors:  Chang-Hua Chen; Hiu-Ngar Sy; Li-Jhen Lin; Hua-Cheg Yen; Shao-Hung Wang; Wei-Liang Chen; Yu-Min Chen; Yu-Jun Chang
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-05-12

Review 8.  Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies.

Authors:  Onyema Ogbuagu; Merceditas Villanueva
Journal:  Infect Dis Rep       Date:  2014-11-19

9.  Gastrointestinal cryptococcoma - Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS?

Authors:  Abdu K Musubire; David B Meya; Robert Lukande; Andrew Kambugu; Paul R Bohjanen; David R Boulware
Journal:  Med Mycol Case Rep       Date:  2015-03-26

10.  Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome.

Authors:  Seher Anjum; Owen Dean; Peter Kosa; M Teresa Magone; Kelly A King; Edmond Fitzgibbon; H Jeff Kim; Chris Zalewski; Elizabeth Murphy; Bridgette Jeanne Billioux; Jennifer Chisholm; Carmen C Brewer; Chantal Krieger; Waleed Elsegeiny; Terri L Scott; Jing Wang; Sally Hunsberger; John E Bennett; Avindra Nath; Kieren A Marr; Bibiana Bielekova; David Wendler; Dima A Hammoud; Peter Williamson
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.